Thiotepa Other names: Triethylene Thiophosphoramide

Chemical formula: C₆H₁₂N₃PS  Molecular mass: 189.218 g/mol  PubChem compound: 5453

Therapeutic indications

Thiotepa is indicated for:

Malignant lymphoma

Population group: only adults (18 years old or older)

Malignant lymphoma

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Central nervous system lymphoma

Population group: only adults (18 years old or older)

Microglioma

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Multiple myeloma

Population group: only adults (18 years old or older)

Multiple myeloma (clinical)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Breast cancer

Population group: only adults (18 years old or older)

Malignant tumor of breast

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Malignant neoplasm of central nervous system

Population group: only adults (18 years old or older)

Malignant neoplasm of central nervous system

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ovarian cancer

Population group: women, only adults (18 years old or older)

Malignant tumour of ovary

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Germ cell tumor

Population group: only adults (18 years old or older)

Germ cell tumour

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Leukemia

Population group: only adults (18 years old or older)

Leukaemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Thalassemia

Population group: only adults (18 years old or older)

Thalassemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Malignant neoplasm of central nervous system

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Malignant neoplasm of central nervous system

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Leukemia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Leukaemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Thalassemia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Thalassemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Refractory cytopenia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

† Refractory cytopenia with multilineage dysplasia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Sickle cell anaemia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Sickle cell anemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Thiotepa is contraindicated in the following cases:

Live virus and bacterial vaccines, yellow fever vaccine

at least one of
Live organism vaccines
Yellow fever vaccines

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: TEPADINA Powder for concentrate for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈